The Effect of Cord Blood Serum Eyes Drops Administer in Patients With Severe Keratopathy Related to EGFR-I Treatment

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-12

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study aim to evaluate the efficacy of cord blood eye drops in the healing of the damaged corneal epithelium.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Blood Based Eyedrops From Different Sources in the Treatment of Severe Keratopathy

NCT03064984

Keratopathy Sjogren's Syndrome GVHD - Graft-Versus-Host Disease

UNKNOWN NA

Cord Blood Platelet Poor Plasma Eye Drops

NCT07089511

Dry Eye

RECRUITING NA

Platelet -Rich Plasma (PRP) Injection for the Treatment of Severe Dry Eye

NCT02257957

Dry Eye Sjogren Syndrome

COMPLETED PHASE3

Study to Evaluate Corneal Neurosensory Abnormalities in Patients With Sjögren's Dry Eye

NCT06411132

Sjögren Syndrome Dry Eye

TERMINATED

The Effect of 0.05% CsA Eye Drops on Diabetic Patients with Dry Eye Disease

NCT06824844

Dry Eye

COMPLETED PHASE4

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients undergoing treatment with EGFR inhibitor for lung cancer might develop corneal damage.

The study aims to evaluate the healing of corneal epithelium by administering cord blood eye drops for one month.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dry Eye

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

eye drops derived from cordonal blood serum

patients who are given eye drops

Group Type EXPERIMENTAL

administration cord blood based eye drops, standardized to the deliver BDNF.

Intervention Type DRUG

administration cord blood based eye drops customized to deliver epitelio tropic factors, incluiding EGF in EGFR blocked cells

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

administration cord blood based eye drops, standardized to the deliver BDNF.

administration cord blood based eye drops customized to deliver epitelio tropic factors, incluiding EGF in EGFR blocked cells

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age over 18 years
* oncology and advanced cancer patients who have EGFr mutation and who require treatment with antiEGFr drugs
* signing of informed consent